Nautilus Biotechnolgy, Inc. Common Stock

NAUT XNAS • LABORATORY ANALYTICAL INSTRUMENTS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

340M

Short interest (May 15)

0.6%

Borrow Fee

0.41%

↓ 1.0%

Available Shares

↓ 14.3%

Price Chart

Company Overview

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Company Info

Exchange: NASDAQ

Industry: LABORATORY ANALYTICAL INSTRUMENTS

CIK: 0001808805

Asset Type: CS

Market Data

Market Cap: $340,571,331

Employees: 130

Status: Active

Short Interest

Current Borrow Fee 0.41%

Range: 0.40% - 0.41%

Available Shares 2M

Range: 1.6M - 3M

Recent Changes

Fee Change: ↑ 0.3%

Available Change: ↓ 25.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime